Submitted:
19 March 2023
Posted:
20 March 2023
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Methods
2.1. Questionnaire Development
- Demographics
- 5-point Likert scale questions on patients’ satisfaction with initial registration on Wasfaty at the University Medical Centre
- patients’ perceptions of the availability of medicines through Wasfaty and the challenges they may have experienced
- The role of community pharmacists in this program
- The use of supporting technology software associated with the Wasfaty service
2.2. Analysis
3. Results
3.1. Respondents’ Satisfaction with Wasfaty EPS
3.2. Community Pharmacists Role in Wasfaty EPS
3.3. Supporting Technology Software for Wasfaty EPS
3.4. Respondents’ Perceptions on How to Improve Wasfaty EPS
4. Discussion
4.1. Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Mizranita V, Sim TF, Sunderland B, Parsons R, Hughes JD. Pharmacists’ and pharmacy technicians’ scopes of practice in the management of minor ailments at community pharmacies in Indonesia: A cross-sectional study. Pharm Pract (Granada). 2021;19 (2):2295–2295. [CrossRef]
- Rupp MT, Warholak TL. Evaluation of e-prescribing in chain community pharmacy: Best-practice recommendations. J Am Pharm Assoc [Internet]. 2008 May;48(3):364-391a. Available online: https://linkinghub.elsevier.com/retrieve/pii/S1544319115312061.
- Olufunmilola, K. Odukoya, and Michelle A. Chui, PhD P. Relationship between E-Prescriptions and Community Pharmacy Workflow. 2013;52(2003). [CrossRef]
- Almaghaslah D, Alsayari A, Almaghaslah S, Alsanna H. Patients’ Satisfaction with E-Prescribing (Wasfaty) in Saudi Arabia: A Survey of Country-Level Implementation. Healthcare [Internet]. 2022 Apr 27;10(5):806. Available online: https://www.mdpi.com/2227-9032/10/5/806.
- Oxford business group. Saudi Arabia optimising pharmaceutical manufacturing and supply chains [Internet]. Available online: https://oxfordbusinessgroup.com/reports/saudi-arabia/2022-report/health-life-sciences/healthy-payoff-investment-in-local-pharmaceuticals-manufacturing-and-modernisation-of-processes-proves-beneficial/.
- Alomi YA, Alghamdi SJ, Alattyh RA. National Corporate Pharmacy and Therapeutic Committee at the Ministry of Health, Saudi Arabia. Pharmacol Toxicol Biomed Reports [Internet]. 2019 Mar 25;4(3):24–7. Available online: http://ptbreports.org/article/2018/4/3/105530ptb201849.
- Ministry of Health * MOH News. Over 24,000 Prescriptions Dispensed via ‘Wasfaty’ Service in Jazan. Available online: https://www.moh.gov.sa/en/Ministry/MediaCenter/News/Pages/News-2020-12-10-003.aspx.
- Ahmed Elnour A. The Future of Pharmacist’s Prescribing in Developing Countries. SOJ Pharm Pharm Sci [Internet]. 2014; 1:2014. Available online: http://symbiosisonlinepublishing.com/pharmacy-pharmaceuticalsciences/pharmacy-pharmaceuticalsciences07.php.
- AlAzmi AA, AlHamdan H, Ahmed O et al. Impact of the e-prescribing system on the incidence and nature of drug-related problems in children in a Saudi hospital. Int J Pharm Pr [Internet]. 2019;Dec;27(6). Available online: https://pubmed.ncbi.nlm.nih.gov/31168945/.
- Bonilla Guijarro A, Bonilla Guijarro E, Bailén M, Hernando A. Percepción y satisfacción del paciente con el sistema de receta electrónica: resultados del cuestionario PERSA-RE. Farm Comunitarios. 2022;14(1):9–16. [CrossRef]
- Alruthia YS, Alwhaibi M, Alotaibi MF et al Drug shortages in Saudi Arabia: Root causes and recommendations. Saudi Pharm J [Internet]. 2018;26(7):947–51. [CrossRef]
- Tawfik EA, Tawfik AF, Alajmi AM, Badr MY, Al-jedai A, Almozain NH, et al. Localizing pharmaceuticals manufacturing and its impact on drug security in Saudi Arabia. Saudi Pharm J [Internet]. 2022 Jan;30(1):28–38. Available online: https://linkinghub.elsevier.com/retrieve/pii/S1319016421002498.
- Al-Hanawi MK, Alsharqi O, Almazrou S, Vaidya K. Healthcare Finance in the Kingdom of Saudi Arabia: A Qualitative Study of Householders’ Attitudes. Appl Health Econ Health Policy [Internet]. 2018 Feb 20;16(1):55–64. Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797208/.
- Alqutub ST. Assessment of Beneficiaries’ Satisfaction with Access to Health Care and Barriers within the Health Delivery System in Saudi Arabia. Saudi J Heal Syst Res [Internet]. 2022 Dec 6;2(4):156–63. Available online: https://www.karger.com/Article/Pdf/527562.
- Tobaiqy M, Thomas D, MacLure A K et al. Staff and student experiences and attitudes towards smoking and smoking cessation, University of Jeddah, Saudi Arabia. Tob Prev Cessat. 2021 Dec 17;7:73. [CrossRef]
| Variables | No | % |
|---|---|---|
| Gender | ||
| Female | 125 | 57.6 |
| Male | 92 | 42.4 |
| Age group | ||
| 18–25 years | 81 | 37.3 |
| 26–32 years | 11 | 5.1 |
| 33–40 years | 47 | 21.7 |
| > 40 years | 78 | 35.9 |
| Educational level | ||
| High school level | 26 | 12.0 |
| University level | 120 | 55.1 |
| Postgraduate level | 71 | 32.9 |
| Employment status | ||
| Student | 83 | 38.4 |
| Staff | 134 | 61.6 |
| Survey Questions | No. | % |
|---|---|---|
| The procedure of initial registration of Wasfaty service at the University Medical Centre was satisfying | ||
| Strongly Agree | 124 | 57.2 |
| Agree | 59 | 27.4 |
| Neutral | 23 | 10.7 |
| Disagree | 3 | 1.4 |
| Strongly Disagree | 7 | 3.3 |
| You have received a text-message with the prescription link within a short time | ||
| Strongly Agree | 121 | 55.6 |
| Agree | 58 | 26.9 |
| Neutral | 23 | 10.6 |
| Disagree | 8 | 3.7 |
| Strongly Disagree | 7 | 3.2 |
| The location of the community pharmacy where the medicines were dispensed was satisfying |
|
|
| Yes | 159 | 73.3% |
| No | 58 | 26.7 |
| You found all the medicines at the community pharmacy close to you | ||
| Strongly Agree | 67 | 30.7 |
| Agree | 42 | 19.5 |
| Neutral | 43 | 20.0 |
| Disagree | 42 | 19.5 |
| Strongly Disagree | 22 | 10.2 |
| You had to visit more than one pharmacy to look for your medicines | ||
| Strongly Agree | 74 | 34.3 |
| Agree | 64 | 29.6 |
| Neutral | 38 | 17.6 |
| Disagree | 26 | 12.0 |
| Strongly Disagree | 14 | 6.5 |
| You are satisfied with the pharmaceutical service you had received at the community pharmacy | ||
| Strongly Agree | 93 | 43.0 |
| Agree | 82 | 38.0 |
| Neutral | 28 | 13.0 |
| Disagree | 7 | 3.2 |
| Strongly Disagree | 6 | 2.8 |
| Your medicines were dispensed accurately by the community pharmacist as prescribed through Wasfaty and you received full explanation on how to use them |
|
|
| Strongly Agree | 99 | 45.4 |
| Agree | 69 | 31.9 |
| Neutral | 35 | 16.2 |
| Disagree | 8 | 3.7 |
| Strongly Disagree | 6 | 2.8 |
| You found your medicines at the community pharmacy but the pharmacist refused to dispense them through Wasfaty service |
|
|
| Strongly Agree | 23 | 10.7 |
| Agree | 17 | 7.9 |
| Neutral | 37 | 17.2 |
| Disagree | 68 | 31.2 |
| Strongly Disagree | 72 | 33.0 |
| The pharmacist dispensed a different medicine from the one the doctor prescribed without consulting him/her |
|
|
| Strongly Agree | 19 | 8.8 |
| Agree | 19 | 8.8 |
| Neutral | 40 | 18.6 |
| Disagree | 74 | 34.0 |
| Strongly Disagree | 65 | 29.8 |
| When the medicines were unavailable, the community pharmacist directed you to another pharmacy branch that may provide your medicines | ||
| Strongly Agree | 59 | 27.4 |
| Agree | 59 | 27.4 |
| Neutral | 61 | 27.9 |
| Disagree | 23 | 10.7 |
| Strongly Disagree | 14 | 6.5 |
| When the pharmacist directed you to another pharmacy to collect your medicines, what did you do? | ||
| Purchased your medicines on your own | 112 | 51.40 |
| Returned to the University main pharmacy | 36 | 16.70 |
| contacted Wasfaty | 34 | 15.70 |
| Other | 35 | 16.20 |
| You know that there is a WhatsApp number for more information about Wasfaty services | ||
| Strongly Agree | 25 | 11.7 |
| Agree | 27 | 12.6 |
| Neutral | 33 | 15.0 |
| Disagree | 74 | 34.1 |
| Strongly Disagree | 58 | 26.6 |
| You are aware of the toll-free number to contact Wasfaty in case of unavailable medicines | ||
| Strongly Agree | 28 | 13.0 |
| Agree | 33 | 15.3 |
| Neutral | 33 | 15.3 |
| Disagree | 62 | 28.4 |
| Strongly Disagree | 61 | 27.9 |
| You are aware of the platform for Wasfaty in Tawakkalna application that displays your prescription | ||
| Strongly Agree | 41 | 18.7 |
| Agree | 39 | 17.8 |
| Neutral | 26 | 12.1 |
| Disagree | 63 | 29.0 |
| Strongly Disagree | 49 | 22.4 |
| You are aware of free home delivery service in case of unavailable medicines by contacting a toll-free number | ||
| Strongly Agree | 29 | 13.2 |
| Agree | 20 | 9.4 |
| Neutral | 34 | 15.6 |
| Disagree | 63 | 29.2 |
| Strongly Disagree | 71 | 32.5 |
| In general, you are satisfied and happy about Wasfaty services | ||
| Strongly Agree | 80 | 36.7 |
| Agree | 68 | 31.2 |
| Neutral | 41 | 19.1 |
| Disagree | 17 | 7.9 |
| Strongly Disagree | 11 | 5.1 |
| Preferred not to submit a suggestion via the questionnaire |
n 120 |
| Express gratitude and appreciation for the services received | 25 |
| Voiced their displeasure at the lack of access to certain pharmaceuticals including anti-hypertensives, anti-diabetics, cosmetics, colds and flu medications | 23 |
| Emphasized the necessity to increase advertising campaigns | 8 |
| Expanding pharmacy locations and expanding partnerships with pharmacies | 7 |
| Improvement of services | 7 |
| Make it possible to check the stock status of medications at individual locations through a central database. | 5 |
| An adequate explanation of the platform | 4 |
| Enhance Response speed | 3 |
| Maintaining a regular schedule of at-home chronic disease treatments | 3 |
| Communicating with the patients after dispensing the medication | 3 |
| Educating pharmacists about the platform | 3 |
| Adding alternatives if the medicine is unavailable. | 3 |
| Connecting “Wasfaty” to the medical center and health centers | 2 |
| Automatic prescription refill | 1 |
| Medicine | Number of e-prescriptions | Percent (%) | |
|---|---|---|---|
| MULTIVITAMINS: TABLETS [ORAL] | 718 | 19.5 | |
| VITAMIN B COMPLEX FILM COATED TABLETS [ORAL] | 572 | 15.6 | |
| MOMETASONE FUROATE: 0.05% SPRAY [NASAL] | 545 | 14.8 | |
| LORATADINE: 10 MG TABLETS [ORAL] | 381 | 10.4 | |
| COLECALCIFEROL: 50000 INTERNATIONAL UNITS CAPSULES [ORAL] | 319 | 8.7 | |
| OMEPRAZOLE: 20 MG CAPSULES [ORAL] | 259 | 7.0 | |
| METFORMIN HCL: 500 MG TABLETS [ORAL] | 251 | 6.8 | |
| ESOMEPRAZOLE: 20 MG GASTRO-RESISTANT TABLETS [ORAL] | 220 | 6.0 | |
| ROSUVASTATIN (AS CALCIUM): 10 MG FILM COATED TABLETS [ORAL] | 211 | 5.7 | |
| PARACETAMOL: 500 MG TABLETS [ORAL] | 201 | 5.5 | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).